Guardant Health (GH) Treasury Shares (2025)

Guardant Health has reported Treasury Shares for 1 years, with the latest figure at $45.0 million in Q3 2025.

• Quarterly Treasury Shares fell 26.15% year-over-year to $5.8 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $5.8 million (down 26.15% YoY) and the FY2025 annual result came in at $6.3 million, down 10.04% from the prior year.
• Treasury Shares slipped to $5.8 million in Q2 2026 per GH's latest filing, from $7.1 million in the prior quarter.
• Over five years, Treasury Shares peaked at $8.4 million in Q1 2025 and troughed at $2.3 million in Q1 2022.
• A 5-year average of $5.1 million and a median of $5.1 million in 2024 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2022 and 2026: Treasury Shares jumped 146.1% in 2022, then decreased 26.15% in 2026.
• Over 5 years, Treasury Shares stood at $3.7 million in 2022, then advanced by 17.87% to $4.3 million in 2023, then soared by 61.5% to $7.0 million in 2024, then decreased by 10.04% to $6.3 million in 2025, then dropped by 7.96% to $5.8 million in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $45.0 million, $45.0 million, and $45.0 million for Q3 2025, Q2 2025, and Q1 2025 respectively.